Inventor · disambiguated record
Silvia Pavan
Also filed as: PAVAN SILVIA
14 granted patents·11 pending applications·241 citations·filing 2015–2025
94Inventor score
Top patents by PatentIndex Score
25 records- 0197US11833211B2Methods of suppression and treatment of disease comprising administering bicycle peptide ligands specific for EphA2BICYCLETX LTD·Filed 2022·Granted Dec 5, 2023·15 cites·20 claims
- 0297US11241473B2Bicyclic peptide ligands and uses thereofBICYCLETX LTD·Filed 2020·Granted Feb 8, 2022·16 cites·27 claims
- 0396US11672868B2Bicyclic peptide ligands specific for MT1-MMPBICYCLERD LTD·Filed 2021·Granted Jun 13, 2023·16 cites·19 claims
- 0496US11484602B2Bicyclic peptide ligands specific for EphA2BICYCLETX LTD·Filed 2018·Granted Nov 1, 2022·16 cites·21 claims
- 0596US11103591B2Bicyclic peptide ligands specific for MT1-MMPBICYCLERD LTD·Filed 2019·Granted Aug 31, 2021·20 cites·24 claims
- 0696US10792368B1Bicyclic peptide ligands specific for MT1-MMPBICYCLERD LTD·Filed 2020·Granted Oct 6, 2020·23 cites·14 claims
- 0795US11696956B2Bicyclic peptide ligands specific for EphA2BICYCLETX LTD·Filed 2018·Granted Jul 11, 2023·18 cites·19 claims
- 0895US10994019B2Bicyclic peptide-toxin conjugates specific for MT1-MMPBICYCLERD LTD·Filed 2017·Granted May 4, 2021·20 cites·17 claims
- 0995US10857196B2Bicyclic peptide ligands and uses thereofBICYCLETX LTD·Filed 2018·Granted Dec 8, 2020·20 cites·20 claims
- 1094US11814447B2Peptide ligands for binding to EphA2BICYCLERD LTD·Filed 2019·Granted Nov 14, 2023·14 cites·19 claims
- 1194US11730819B2Peptide derivatives having novel linkage structuresBICYCLETX LTD·Filed 2017·Granted Aug 22, 2023·15 cites·23 claims
- 1294US11623012B2Bicyclic peptide ligands specific for EphA2BICYCLERD LTD·Filed 2018·Granted Apr 11, 2023·15 cites·9 claims
- 1394US10532106B2Bicyclic peptide ligands specific for MT1-MMPBICYCLERD LTD·Filed 2015·Granted Jan 14, 2020·32 cites·12 claims
- 1493US12318454B2Bicyclic peptide ligands specific for MT1-MMPBICYCLERD LTD·Filed 2023·Granted Jun 3, 2025·1 cites·13 claims
- 1585US2024189436A1BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EphA2BICYCLETX LTD·Filed 2023·Application pending·0 cites
- 1683US2024000957A1BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EphA2BICYCLETX LTD·Filed 2023·Application pending·0 cites
- 1782US2025255975A1Bicyclic peptide ligands specific for mt1-mmpBICYCLERD LTD·Filed 2025·Application pending·0 cites
- 1873US2023340020A1Peptide ligands for binding to mt1-mmpBICYCLETX LTD·Filed 2022·Application pending·0 cites
- 1972US2025230191A1Peptide ligands for binding to mt1-mmpBICYCLETX LTD·Filed 2025·Application pending·0 cites
- 2062US2019389907A1Peptide ligands for binding to mt1-mmpBICYCLETX LTD·Filed 2017·Application pending·0 cites
- 2152US2022194983A1Peptide ligands for binding to psmaBICYCLETX LTD·Filed 2019·Application pending·0 cites
- 2251US2021122785A1Peptide ligands for binding to il-17BICYCLETX LTD·Filed 2019·Application pending·0 cites
- 2351US2021147485A1Peptide ligands for binding to integrinBICYCLETX LTD·Filed 2019·Application pending·0 cites
- 2451US2021122804A1Peptide ligands for binding to cd38BICYCLETX LTD·Filed 2019·Application pending·0 cites
- 2549US2022133733A1Bicyclic peptide ligands specific for cd38BICYCLERD LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Silvia Pavan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →